PM

Patricia Martin

CEO

Indianapolis, Indiana

Overview 

Patricia Martin is a seasoned executive with over 25 years of experience in the global BioPharma industry, currently serving as the President and CEO of BioCrossroads, where she is dedicated to advancing Indiana's life sciences sector through research and collaboration. With a Master of Business Administration from Harvard Business School and a Bachelor of Science from Indiana University, she has held board member positions at various organizations like Goodwill Foundation, Leap Therapeutics, and AN2 Therapeutics, showcasing her strong leadership and strategic acumen in the industry. Patricia's career highlights include leading BioCrossroads to champion Indiana's life sciences ecosystem through seed funding and serving on the board of multiple influential organizations in the healthcare and biotechnology sectors, demonstrating her commitment to driving innovation and growth in the industry.

Work Experience 

  • Board Member

    2023

    NASDAQ: LPTX

Leap Therapeutics is a clinical-stage biopharmaceutical company for development of targeted and immuno-oncology therapeutics.

Raised $266,500,000.00 from Laurion Capital Management, 683 CAPITAL, Samsara BioCapital, Rock Springs Capital, Gilead Sciences, BeiGene, Lincoln Park Capital Fund and Eli Lilly & Company Foundation.

  • Board Member

    2021

    NASDAQ: ANTX

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Raised $162,000,000.00 from Bill & Melinda Gates Foundation and Bill & Melinda Gates Foundation.

  • Board Member

    2021

    Finance/Audit Committee Chair

Regenstrief Institute is a medical R&D organization in electronic medical records and health care data integration.

  • Board Member

    2015 - 2023

    Board Member, Compensation Committee - Chair, Risk Committee - Member To make a lasting difference in our members’ lives by improving their health and well-being.

  • President and CEO | Advancing Indiana's Life Sciences Sector via Research and Collaboration

    2019 - 2023

BioCrossroads is a venture capital firm specializing in life sciences companies based in Indiana.

Raised $1,480,000.00 from Richard M. Fairbanks Foundation.

  • Managing Partner | Championing Indiana's Life Sciences Ecosystem through Seed Funding

    2019 - 2023

  • Interim CEO

    2021 - 2023

    Led wind-down of operations and merger negotiations and integration into Leap Therapeuticx, Incl (LPTX)

  • Board Member

    2020 - 2023

Articles About Patricia

Relevant Websites